2Paul IM.Advances in pediatric pharmacology,therapeutics,and toxicology[J].Adv Pediatr,2005,52:321-365.
3Choonara I.Regulation of drugs for children in Europe[J].BMJ,2007,335(7632):1221-1222.
4Mac Leod S,Peterson R,Wang Y,et al.Challenges in international pediatric pharmacology:a milestone meeting in Shanghai[J].Pediatr Drugs,2007,9(4):215-218.
5Nordic Pharmacology Society.Compilation Clinical pharmacology in research,teaching and health care[J].Basic & Clinical Pharmacology & Toxicology,2010,107:531-559.
同被引文献92
1Tanaka K, Pippenger CE, Mimaki T, et al. Advances in therapeutic drug monitoring. Proceedings of the 1 st intemational Congress of TDM [ M]. Enterprise: Tokyo, 1990.
2Li wang, et al. Clinical value of determination of serum concentration of antiepileptics [ J ]. Chinese Medical Journal, 1984, 97 : 165-170.
3Nordic Pharmacology Society. Compilation Clinical pharmacology in research, teaching and health care [ J ]. Basic & Clinical Pharmacology & Toxicology, 2010, 107: 531-559.
4MacLeod S, Peterson R, Wang Y, et al. Challenges in international pediatric pharmacology: a milestone meeting in Shanghai [J]. Pediatric Drugs, 2007, 9(4) : 215-218.
5Shirkey H. Therapeutic orphans. J Pediatrics, 1968,72 : 119-120.
6Gazarian M. Why are children still therapeutic orphans? Aust Prescr,2003 ,26 :122-123.
7Stoyanova-Beninska VV, Wohlfarth T, Isaac M, et al. The EU Paediatric regulation: effects on pediatric psychopharmacology in Europe. Eurpean Neurosychopharmacolol, 2011,21:565-570.
8Choonara I. Regulation of drugs for children in Europe. BMJ, 2007, 335: 1221-1222.
9Pasquali SK, Lam WK, Chiswell K, et al. Status of the pediatric clinical trials enterprise: an analysis of the US Clinical Trials. gov registry. Pediatrics, 2012,130 : e1269-1277.
10Shah SS, Hall M,Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med, 2007,161:282-290.
